Hypertension (high blood pressure) Board decisions

The Board has denied the Veteran's claims for service connection for lumbar strain with arthritis, shortness of breath, hypertension, bilateral lower extremity neuropathy, and tinnitus in excess of 10 percent.,There is no evidence showing a current disability for any of these conditions.

The Veteran's claims for cerebrovascular strokes and chronic lymphocytic leukemia (CLL) are denied as there is no evidence of a nexus between these conditions and his military service.

The Board denied service connection for bilateral hearing loss, hypertension, a back condition, and both lower extremity neuropathy conditions due to the lack of evidence showing these conditions had their onset during active duty for training (ACDUTRA).

The Veteran's claims for a higher rating for hypertension, an earlier effective date for TDIU and DEA benefits were all denied. The Board found that the Veteran's hypertension did not meet the criteria for a compensable rating due to his blood pressure readings being controlled with medication. For TDIU and DEA, the Board determined that the Veteran was not unemployable prior to March 17, 2023, as he had other service-connected disabilities rated at 60 percent or more combined.

The Veteran's bladder cancer, hypertension, Bowen's disease (skin condition), thyroid condition (hypothyroidism/hyperthyroidism), back disability, left hip disability, osteopenia/osteoporosis, and right foot vascular disorder are all granted as presumptively related to herbicide exposure. The Veteran's service-connected bilateral knee disabilities are also found to be secondary to these conditions.

The Board has granted a TDIU effective December 1, 2022 due to the Veteran's service-connected disabilities preventing him from obtaining and maintaining suitable employment. The decision is based on his hypertension, prostate cancer, and other specified trauma/stressor-related disorder.

The Board has granted effective dates of August 10, 2022 for hypertension and July 25, 2023 for diabetes mellitus, type II, bilateral lower extremity diabetic peripheral neuropathy, a bilateral hearing loss disability, and tinnitus.,The Veteran's conditions were found to have manifested no later than the dates specified in their respective effective dates.

The Veteran's hypertension is granted a 10 percent rating.,Service connection for diverticulitis and basal cell carcinoma/skin cancer residuals with scarring are denied.

The Board has denied the Veteran's appeals for service connection due to late filing of appeal requests, and thus dismissed the attempts.

The Board has remanded the case due to a duty to assist error, specifically regarding the Veteran's hypertension. The AOJ is instructed to obtain medical records from Dr. Banton and provide an addendum opinion on the etiology of the Veteran's hypertension.

The Board has determined that hypertension is related to the Veteran's service-connected posttraumatic stress disorder (PTSD) and obstructive sleep apnea, granting service connection for this condition.

The Veteran's hypertension was rated as noncompensable, and his erectile dysfunction was also rated as noncompensable.,Both conditions were already assigned the maximum schedular ratings available.

Service connection for diabetes mellitus Type II is granted. The Board also found that service connection should be granted for hypertension and paroxysmal atrial fibrillation as secondary to the Veteran's diabetes mellitus.

The Board has granted an earlier effective date of October 4, 2021 for service connection for hypertension on a facts-found basis. The reduction in the rating from 20 percent to 10 percent for bilateral hearing loss is denied as it was not based on evidence of improvement.

The Veteran's appeals for service connection and ratings were dismissed due to his withdrawal of the appeal seeking service connection for bronchitis, hypertension, and a compensable rating for tinea pedis prior to the promulgation of a decision.

The Veteran's hypertension was granted a 10 percent rating, effective June 21, 2023. His edema of the bilateral lower extremities is also service-connected as secondary to his hypertension.

The Veteran's appeals for increased ratings for left thumb degenerative arthritis and surgical scars, as well as service connection for hypertension secondary to PTSD, were all denied by the Board of Veterans' Appeals.

The Veteran's claims for service connection are being remanded due to the AOJ failing to obtain relevant private treatment records from Dr. K.

The Board has remanded the Veteran's claims for service connection for coronary artery disease, high blood pressure, diabetes mellitus, type II, and skin cancer due to potential exposure to Agent Orange during his military service. The AOJ is instructed to develop the record further regarding the Veteran's claimed locations prior to boarding the USS Coral Sea and obtain a medical opinion on the nature and likely etiology of the Veteran's hypertension and skin cancer.

The Veteran's appeals seeking a compensable initial rating and an effective date earlier than August 29, 2023, for service connection of hypertension have been dismissed due to the Veteran's representative withdrawing the appeals prior to hearing.